Kathleen E. DelGiorno, Ph.D. - Publications

Affiliations: 
2012 Molecular Genetics and Microbiology Stony Brook University, Stony Brook, NY, United States 
Area:
Cell Biology, Microbiology Biology

30 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Salas-Escabillas DJ, Hoffman MT, Moore JS, Brender SM, Wen HJ, Benitz S, Davis ET, Long D, Wombwell AM, Steele NG, Sears RC, Matsumoto I, DelGiorno KE, Crawford HC. Metaplastic tuft cells transdifferentiate to neural-like progenitor cells in the progression of pancreatic cancer. Biorxiv : the Preprint Server For Biology. PMID 38405804 DOI: 10.1101/2024.02.12.579982  0.61
2023 DelGiorno K. CD73 Is a Critical Immune Checkpoint in a Molecular Subtype of Pancreatic Cancer. Cancer Research. 83: 977-978. PMID 37014046 DOI: 10.1158/0008-5472.CAN-23-0268  0.356
2022 Gubbala VB, Jytosana N, Trinh VQ, Maurer HC, Naeem RF, Lytle NK, Ma Z, Zhao S, Lin W, Han H, Shi Y, Hunter T, Singh PK, Olive KP, Tan MCB, ... ... DelGiorno KE, et al. Eicosanoids in the pancreatic tumor microenvironment - a multicellular, multifaceted progression. Gastro Hep Advances. 1: 682-697. PMID 36277993 DOI: 10.1016/j.gastha.2022.02.007  0.351
2022 Caplan LR, Vavinskaya V, Gelikman DG, Jyotsana N, Trinh VQ, Olive KP, Tan MCB, DelGiorno KE. Enteroendocrine Cell Formation Is an Early Event in Pancreatic Tumorigenesis. Frontiers in Physiology. 13: 865452. PMID 35574446 DOI: 10.3389/fphys.2022.865452  0.347
2020 DelGiorno KE, Chung CY, Vavinskaya V, Maurer HC, Novak SW, Lytle NK, Ma Z, Giraddi RR, Wang D, Fang L, Naeem RF, Andrade LR, Ali WH, Tseng H, Tsui C, et al. Tuft Cells Inhibit Pancreatic Tumorigenesis in Mice by Producing Prostaglandin D2. Gastroenterology. PMID 32717220 DOI: 10.1053/J.Gastro.2020.07.037  0.49
2020 Badgley MA, Kremer DM, Maurer HC, DelGiorno KE, Lee HJ, Purohit V, Sagalovskiy IR, Ma A, Kapilian J, Firl CEM, Decker AR, Sastra SA, Palermo CF, Andrade LR, Sajjakulnukit P, et al. Cysteine depletion induces pancreatic tumor ferroptosis in mice. Science (New York, N.Y.). 368: 85-89. PMID 32241947 DOI: 10.1126/Science.Aaw9872  0.449
2020 DelGiorno KE, Naeem RF, Fang L, Chung CY, Ramos C, Luhtala N, O'Connor C, Hunter T, Manor U, Wahl GM. Tuft Cell Formation Reflects Epithelial Plasticity in Pancreatic Injury: Implications for Modeling Human Pancreatitis. Frontiers in Physiology. 11: 88. PMID 32116793 DOI: 10.3389/Fphys.2020.00088  0.46
2019 Shi Y, Gao W, Lytle NK, Huang P, Yuan X, Dann AM, Ridinger-Saison M, DelGiorno KE, Antal CE, Liang G, Atkins AR, Erikson G, Sun H, Meisenhelder J, Terenziani E, et al. Targeting LIF-mediated paracrine interaction for pancreatic cancer therapy and monitoring. Nature. PMID 30996350 DOI: 10.1038/S41586-019-1130-6  0.478
2019 Hoffman MT, Salas-Escabillas DJ, DelGiorno KE, Bednar F, Margolskee RF, Rao A, Crawford HC. Abstract A19: The role of metaplastic tuft cell chemosensory signaling in pancreatic cancer Cancer Research. 79. DOI: 10.1158/1538-7445.Panca19-A19  0.645
2019 DelGiorno KE, Chung C, Giraddi R, Ke E, Maurer HC, Ridinger-Saison M, Ali WH, Tsui C, Ramos C, Naeem R, Ohmoto M, Fang L, Luna G, Fitzpatrick C, O'Connor C, et al. Abstract 5169: Pancreatic tumorigenesis evokes mechanisms of tissue injury and repair Cancer Research. 79: 5169-5169. DOI: 10.1158/1538-7445.Am2019-5169  0.484
2018 DelGiorno KE, Chung C, Ridinger M, Ali W, Tsui C, Ramos C, Ohmoto M, Fang L, Manor U, Matsumoto I, Wahl GM. Abstract 992: Pancreatic tuft cells resolve injury and restrain tumorigenesis Cancer Research. 78: 992-992. DOI: 10.1158/1538-7445.Am2018-992  0.386
2017 Saison-Ridinger M, DelGiorno KE, Zhang T, Kraus A, French R, Jaquish D, Tsui C, Erikson G, Spike BT, Shokhirev MN, Liddle C, Yu RT, Downes M, Evans RM, Saghatelian A, et al. Reprogramming pancreatic stellate cells via p53 activation: A putative target for pancreatic cancer therapy. Plos One. 12: e0189051. PMID 29211796 DOI: 10.1371/Journal.Pone.0189051  0.461
2016 DuFort CC, DelGiorno KE, Hingorani SR. Mounting Pressure in the Microenvironment: Fluids, Solids, and Cells in Pancreatic Ductal Adenocarcinoma. Gastroenterology. PMID 27072672 DOI: 10.1053/J.Gastro.2016.03.040  0.373
2016 Liou GY, Döppler H, DelGiorno KE, Zhang L, Leitges M, Crawford HC, Murphy MP, Storz P. Mutant KRas-Induced Mitochondrial Oxidative Stress in Acinar Cells Upregulates EGFR Signaling to Drive Formation of Pancreatic Precancerous Lesions. Cell Reports. PMID 26947075 DOI: 10.1016/J.Celrep.2016.02.029  0.597
2016 Carlson MA, Dufort CC, DelGiorno KE, Brockenbrough JS, Dotson AM, Hingorani SR. Abstract A80: Targeted depletion of extracellular matrix components in PDA eases barriers to treatment Cancer Research. 76. DOI: 10.1158/1538-7445.Panca16-A80  0.408
2015 Whittle MC, Izeradjene K, Rani PG, Feng L, Carlson MA, DelGiorno KE, Wood LD, Goggins M, Hruban RH, Chang AE, Calses P, Thorsen SM, Hingorani SR. RUNX3 Controls a Metastatic Switch in Pancreatic Ductal Adenocarcinoma. Cell. 161: 1345-60. PMID 26004068 DOI: 10.1016/J.Cell.2015.04.048  0.477
2015 Takeuchi KK, Delgiorno KE, Halbrook CJ, Crawford HC. Abstract IA13: Acinar cell transdifferentiation sets the stage for early tumor heterogeneity Cancer Research. 75. DOI: 10.1158/1538-7445.Panca2014-Ia13  0.656
2015 DelGiorno KE, Carlson M, Provenzano PP, Brockenbough S, Hingorani SR. Abstract B05: Assessing and removing biophysical barriers to treatment Cancer Research. 75. DOI: 10.1158/1538-7445.Panca2014-B05  0.393
2015 Brockenbrough JS, Feng L, Stromnes IM, DelGiorno KE, Whittle MC, Cuevas C, Dotson AM, Ryan JS, Thorsen SM, Hingorani SR. Abstract A92: Murine clinical trials program Cancer Research. 75. DOI: 10.1158/1538-7445.Panca2014-A92  0.356
2014 Wu CY, Carpenter ES, Takeuchi KK, Halbrook CJ, Peverley LV, Bien H, Hall JC, DelGiorno KE, Pal D, Song Y, Shi C, Lin RZ, Crawford HC. PI3K regulation of RAC1 is required for KRAS-induced pancreatic tumorigenesis in mice. Gastroenterology. 147: 1405-16.e7. PMID 25311989 DOI: 10.1053/J.Gastro.2014.08.032  0.716
2014 Stromnes IM, DelGiorno KE, Greenberg PD, Hingorani SR. Stromal reengineering to treat pancreas cancer. Carcinogenesis. 35: 1451-60. PMID 24908682 DOI: 10.1093/Carcin/Bgu115  0.483
2014 DelGiorno KE, Tam JW, Hall JC, Thotakura G, Crawford HC, van der Velden AW. Persistent salmonellosis causes pancreatitis in a murine model of infection. Plos One. 9: e92807. PMID 24717768 DOI: 10.1371/Journal.Pone.0092807  0.591
2014 Bailey JM, DelGiorno KE, Crawford HC. The secret origins and surprising fates of pancreas tumors. Carcinogenesis. 35: 1436-40. PMID 24583923 DOI: 10.1093/Carcin/Bgu056  0.605
2014 Delgiorno KE, Hall JC, Takeuchi KK, Pan FC, Halbrook CJ, Washington MK, Olive KP, Spence JR, Sipos B, Wright CV, Wells JM, Crawford HC. Identification and manipulation of biliary metaplasia in pancreatic tumors. Gastroenterology. 146: 233-44.e5. PMID 23999170 DOI: 10.1053/J.Gastro.2013.08.053  0.646
2013 Ali WH, Chen Q, Delgiorno KE, Su W, Hall JC, Hongu T, Tian H, Kanaho Y, Di Paolo G, Crawford HC, Frohman MA. Deficiencies of the lipid-signaling enzymes phospholipase D1 and D2 alter cytoskeletal organization, macrophage phagocytosis, and cytokine-stimulated neutrophil recruitment. Plos One. 8: e55325. PMID 23383154 DOI: 10.1371/Journal.Pone.0055325  0.556
2013 DelGiorno K, Takeuchi K, Hall J, Olive K, Wells J, Crawford H. Tumor-associated pancreatic metaplasia assumes a biliary duct gland phenotype Pancreatology. 13: e22. DOI: 10.1016/J.Pan.2012.12.130  0.599
2012 Ardito CM, Grüner BM, Takeuchi KK, Lubeseder-Martellato C, Teichmann N, Mazur PK, Delgiorno KE, Carpenter ES, Halbrook CJ, Hall JC, Pal D, Briel T, Herner A, Trajkovic-Arsic M, Sipos B, et al. EGF receptor is required for KRAS-induced pancreatic tumorigenesis. Cancer Cell. 22: 304-17. PMID 22975374 DOI: 10.1016/J.Ccr.2012.07.024  0.576
2012 DelGiorno KE, Takeuchi K, Halbrook C, Crawford HC. Abstract B73: Tumor-associated pancreatic metaplasia assumes a biliary duct-like phenotype. Cancer Research. 72. DOI: 10.1158/1538-7445.Panca2012-B73  0.67
2010 Bombardelli L, Carpenter ES, Wu AP, Alston N, DelGiorno KE, Crawford HC. Pancreas-specific ablation of beta1 integrin induces tissue degeneration by disrupting acinar cell polarity. Gastroenterology. 138: 2531-40, 2540.e1-4. PMID 20188101 DOI: 10.1053/J.Gastro.2010.02.043  0.7
2008 Demeure MJ, Stephan E, Gonzales P, Han H, Delgiorno K, Grant CS, Gately S, Trent JM, Von Hoff DD. Pre-clinical evidence for nab-paclitaxel efficacy in the treatment of adrenocortical cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 26: 22070. PMID 27950526 DOI: 10.1200/Jco.2008.26.15_Suppl.22070  0.342
Show low-probability matches.